GNH USA

USA — NDC

Besponsa 0.9 mg

Bespansa 0.9 mg is a powder for solution used in intravenous therapy. This medication, containing inotuzumab ozogamicin, is designed for targeted treatment in s

Inotuzumab Ozogamicin
BESPONSA
POWDER FOR SOLUTION
0.9 MG

Request sourcing

1
Pack/s

What is Inotuzumab Ozogamicin?

Bespansa 0.9 mg is a powder for solution used in intravenous therapy. This medication, containing inotuzumab ozogamicin, is designed for targeted treatment in specific medical conditions. Learn more about its uses and effects.

What is Inotuzumab Ozogamicin used for?

Bespansa 0.9 mg is primarily used for targeted therapy in certain types of cancer. It works by attaching to specific cells and delivering a cytotoxic agent. This process helps in reducing the proliferation of targeted cells. Patients often wonder, 'What is Bespansa used for?' It is typically prescribed for conditions where targeted cell destruction is beneficial.

What are the side effects of Inotuzumab Ozogamicin?

Common effects of Bespansa 0.9 mg may include fatigue, fever, and nausea. Some patients also experience infusion-related reactions. These effects can vary widely among individuals. Always consult a healthcare provider for personalized information.

What precautions apply to Inotuzumab Ozogamicin?

Bespansa 0.9 mg should be handled with care. It is important to follow proper storage and administration guidelines. Patients with certain medical conditions or allergies should inform their healthcare provider before use. Always use under medical supervision.

What does Inotuzumab Ozogamicin interact with?

Bespansa 0.9 mg may interact with other medications, including those that affect the immune system. It is advisable to discuss all current medications with a healthcare provider. Avoid alcohol and other substances that may compromise treatment efficacy.

Frequently asked questions

What is Bespansa used for?+
Bespansa 0.9 mg is used for targeted therapy in specific types of cancer. It works by attaching to certain cells and delivering a cytotoxic agent.
How is Bespansa administered?+
Bespansa 0.9 mg is administered intravenously as a powder for solution. It should be prepared and administered by healthcare professionals.
What are the common side effects of Bespansa?+
Common side effects may include fatigue, fever, nausea, and infusion-related reactions. Always consult a healthcare provider for detailed information.
Can Bespansa be used with other medications?+
Bespansa 0.9 mg may interact with other medications. It is important to discuss all current medications with a healthcare provider before starting treatment.
Who should avoid using Bespansa?+
Patients with certain medical conditions or allergies should inform their healthcare provider before using Bespansa 0.9 mg. Always use under medical supervision.
Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.

Product details

Drug
Inotuzumab Ozogamicin
Brand
BESPONSA
Strength
0.9 MG
Form
POWDER FOR SOLUTION
Route
INTRAVENOUS
Manufacturer
PFIZER CANADA ULC
Origin
CANADA

Related products